Mucosolvan syrup 30 mg/5 ml is an expectorant which is used to thin the mucus in acute and chronic bronchial and lung diseases where thick, tenacious mucus is a problem. Before you take Mucosolvan syrup 30 mg/5 ml Do not take Mucosolvan syrup 30 mg/5ml: if you are hypersensitive (allergic) to the active substance (ambroxol …
Mucosolvan has been shown to increase respiratory tract secretion. It enhances pulmonary surfactant production and stimulates ciliary activity. Improvement of mucociliary clearance has been shown in clinical pharmacological studies. Enhancement of fluid secretion and mucociliary clearance facilitates expectoration and eases cough. INDICATIONS Mucosolvan is indicated as mucolytic. DOSAGE Adults and children over 12 years: 10 …
Composition active ingredient Ambroxol Hydrochloride. syrup: each 5 ml contains 15 mg. oral drops : each 5 ml contains 7.5 mg. Therapeutic Indications Mucolytic therapy of acute or chronic bronchopulmonary diseases associated with abnormal mucous secretion and transport disturbances. Posology And Method Of Administration The following dosages are recommended: Age Posology Adults and children older …
It is prohibited to use this medicine for children under 2 years of age completely and it is prohibited to use it for children under 6 years without medical supervision COMPOSITION Each 5 ml of syrup contains: N-acetylcysteine 100 mg. Chlorpheniramine Maleate 2 mg. Excepients: Carboxy methyl cellulose sodium, Disodium edetate, Methyl paraben sodium, propyl …
Composition active ingredient carbocisteine Paediatric syrup: each 5 ml contains 100 mg. excipients: Paediatric syrup: methyl paraben, propylparaben, glycerin, sorbitol 70%,caramel colour, tutti frutti flavour,sodium hydroxide, purified water. therapeutic indications: carbocisteine ( active ingredient ) is a mucolytic agent for the therapy of respiratory tract disorders characterized by excessive viscous mucus including chronic obstructive Airways …
Composition active ingredient carbocisteine adult syrup: each 5 ml contains 250 mg. Paediatric syrup: each 5 ml contains 100 mg. excipients: Adult syrup: methyl paraben, propylparaben, glycerin, sorbitol 70%,caramel colour, strawberry liquid, sodium hydroxide, purified water. Paediatric syrup: methyl paraben, propylparaben, glycerin, sorbitol 70%,caramel colour, tutti frutti flavour,sodium hydroxide, purified water. therapeutic indications: carbocisteine ( …
AVICHEST 100 mg pediatric & 250 mg adult syrup … Mucolytic Read More »
Composition active ingredient carbocisteine adult syrup: each 5 ml contains 250 mg. Paediatric syrup: each 5 ml contains 125 mg. excipients: Adult syrup: methyl paraben, propylparaben, glycerin, sorbitol 70%,caramel colour, strawberry liquid, sodium hydroxide, purified water. Paediatric syrup: methyl paraben, propylparaben, glycerin, sorbitol 70%,caramel colour, tutti frutti flavour,sodium hydroxide, purified water. therapeutic indications: carbocisteine ( …
MUCOSOL 2% pediatric & 5% adult syrup … Mucolytic Read More »
COMPOSITION: Each 5 ml contains Ambroxol Hydrochloride (BP) 15 mg. CLINICAL PHARMACOLOGY: Ambolar has been shown to increase respiratory tract secretion. It enhances pulmonary surfactant production and stimulates ciliary activity. Improvement of mucociliary clearance has been shown in clinical pharmacological studies. Enhancement of fluid secretion and mucociliary clearance facilitates expectoration and eases cough. INDICATIONS Ambolar …
COMPOSITION: Each 5 ml contains Ambroxol Hydrochloride (BP) 15 mg. CLINICAL PHARMACOLOGY: Mucofar has been shown to increase respiratory tract secretion. It enhances pulmonary surfactant production and stimulates ciliary activity. Improvement of mucociliary clearance has been shown in clinical pharmacological studies. Enhancement of fluid secretion and mucociliary clearance facilitates expectoration and eases cough. INDICATIONS Mucofar …
COMPOSITION: Each 5 ml contains Ambroxol Hydrochloride (BP) 15 mg. CLINICAL PHARMACOLOGY: Fluibron has been shown to increase respiratory tract secretion. It enhances pulmonary surfactant production and stimulates ciliary activity. Improvement of mucociliary clearance has been shown in clinical pharmacological studies. Enhancement of fluid secretion and mucociliary clearance facilitates expectoration and eases cough. INDICATIONS Fluibron …